Other
Advanced Stage
0
Pipeline Programs↗
5
Active Trials↗
3
Companies Involved↗
Advanced Stage is an early-stage landscape with 0 programs across 3 companies. The most active players are Johnson & Johnson, Shanghai YingLi Pharmaceutical Co. Ltd., Vertex Pharmaceuticals.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
22
clinical trials
Completed11 · 50%
Active, not recruiting4 · 18%
Terminated2 · 9%
Unknown status2 · 9%
Withdrawn1 · 5%
Recruiting1 · 5%
Other1 · 5%
Clinical Trials
Trial Activity
22 trials
Feasibility and Safety of IMP321 (Eftilagimod Alpha) for Advanced Stage Solid Tumors
Active, not recruiting·IInstitut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest·Phase 1·NCT03252938·83 enrolled
Allogeneic Tissue Engineering (Nanostructured Artificial Human Cornea) in Patients With Corneal Trophic Ulcers in Advanced Stages, Refractory to Conventional (Ophthalmic) Treatment
Completed·AAndalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud·Phase 1/2·NCT01765244·16 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)